ResearcherUniversity of KansasNo recent work listed
Dan A. Dixon
Matched on ORCID iD 0000-0001-5631-4365; OpenAlex author ID A5034221761. Sources: OpenAlex.
Their work
- Papers
- 4 (first author 1, last author 0)
- Trials
- 0
- Grants
- 0
- Labs led
- 0
- Collaborators
- 22
2018: 1 paper · 2019: none · 2020: 1 paper · 2021: 1 paper · 2022: 1 paper
Papers 4
- The RNA-Binding Protein HuR Posttranscriptionally Regulates the Protumorigenic Activator YAP1 in Pancreatic Ductal Adenocarcinoma. Co-author DOI 10.1128/mcb.00018-22↗
- The FDA-Approved Anthelmintic Pyrvinium Pamoate Inhibits Pancreatic Cancer Cells in Nutrient-Depleted Conditions by Targeting the Mitochondria. Co-author DOI 10.1158/1535-7163.mct-20-0652↗
- An RNA-Binding Protein, Hu-antigen R, in Pancreatic Cancer Epithelial to Mesenchymal Transition, Metastasis, and Cancer Stem Cells. Co-author DOI 10.1158/1535-7163.mct-19-0822↗
- Complex HuR function in pancreatic cancer cells. First author DOI 10.1002/wrna.1469↗
Closest collaborators
The 22 strongest of 22 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.
- Jonathan Robert Brody · 3 shared papers, 2018–2022 · strength 0.39
- Paper Complex HuR function in pancreatic cancer cells. DOI 10.1002/wrna.1469↗
- Paper The RNA-Binding Protein HuR Posttranscriptionally Regulates the Protumorigenic Activator YAP1 in Pancreatic Ductal Aden… DOI 10.1128/mcb.00018-22↗
- Paper The FDA-Approved Anthelmintic Pyrvinium Pamoate Inhibits Pancreatic Cancer Cells in Nutrient-Depleted Conditions by Tar… DOI 10.1158/1535-7163.mct-20-0652↗
- Aditi Jain · 2 shared papers, 2021–2022 · strength 0.22
- Paper The RNA-Binding Protein HuR Posttranscriptionally Regulates the Protumorigenic Activator YAP1 in Pancreatic Ductal Aden… DOI 10.1128/mcb.00018-22↗
- Paper The FDA-Approved Anthelmintic Pyrvinium Pamoate Inhibits Pancreatic Cancer Cells in Nutrient-Depleted Conditions by Tar… DOI 10.1158/1535-7163.mct-20-0652↗
- Christopher William Schultz · 2 shared papers, 2021–2022 · strength 0.22
- Paper The RNA-Binding Protein HuR Posttranscriptionally Regulates the Protumorigenic Activator YAP1 in Pancreatic Ductal Aden… DOI 10.1128/mcb.00018-22↗
- Paper The FDA-Approved Anthelmintic Pyrvinium Pamoate Inhibits Pancreatic Cancer Cells in Nutrient-Depleted Conditions by Tar… DOI 10.1158/1535-7163.mct-20-0652↗
- Matthew McCoy · 2 shared papers, 2021–2022 · strength 0.22
- Paper The RNA-Binding Protein HuR Posttranscriptionally Regulates the Protumorigenic Activator YAP1 in Pancreatic Ductal Aden… DOI 10.1128/mcb.00018-22↗
- Paper The FDA-Approved Anthelmintic Pyrvinium Pamoate Inhibits Pancreatic Cancer Cells in Nutrient-Depleted Conditions by Tar… DOI 10.1158/1535-7163.mct-20-0652↗
- Samantha Z. Brown · 2 shared papers, 2021–2022 · strength 0.22
- Paper The RNA-Binding Protein HuR Posttranscriptionally Regulates the Protumorigenic Activator YAP1 in Pancreatic Ductal Aden… DOI 10.1128/mcb.00018-22↗
- Paper The FDA-Approved Anthelmintic Pyrvinium Pamoate Inhibits Pancreatic Cancer Cells in Nutrient-Depleted Conditions by Tar… DOI 10.1158/1535-7163.mct-20-0652↗
- Grace A. McCarthy · 2 shared papers, 2021–2022 · strength 0.22
- Paper The RNA-Binding Protein HuR Posttranscriptionally Regulates the Protumorigenic Activator YAP1 in Pancreatic Ductal Aden… DOI 10.1128/mcb.00018-22↗
- Paper The FDA-Approved Anthelmintic Pyrvinium Pamoate Inhibits Pancreatic Cancer Cells in Nutrient-Depleted Conditions by Tar… DOI 10.1158/1535-7163.mct-20-0652↗
- Charles J. Yeo · 2 shared papers, 2021–2022 · strength 0.22
- Paper The RNA-Binding Protein HuR Posttranscriptionally Regulates the Protumorigenic Activator YAP1 in Pancreatic Ductal Aden… DOI 10.1128/mcb.00018-22↗
- Paper The FDA-Approved Anthelmintic Pyrvinium Pamoate Inhibits Pancreatic Cancer Cells in Nutrient-Depleted Conditions by Tar… DOI 10.1158/1535-7163.mct-20-0652↗
- Avinoam Nevler · 2 shared papers, 2021–2022 · strength 0.22
- Paper The RNA-Binding Protein HuR Posttranscriptionally Regulates the Protumorigenic Activator YAP1 in Pancreatic Ductal Aden… DOI 10.1128/mcb.00018-22↗
- Paper The FDA-Approved Anthelmintic Pyrvinium Pamoate Inhibits Pancreatic Cancer Cells in Nutrient-Depleted Conditions by Tar… DOI 10.1158/1535-7163.mct-20-0652↗
- Thomas Lee Sutton · 1 shared paper, 2022 · strength 0.13
- Rosalie C. Sears · 1 shared paper, 2022 · strength 0.13
- Wei Jiang · 1 shared paper, 2022 · strength 0.13
- Kishore Polireddy · 1 shared paper, 2020 · strength 0.11
- Liang Xu · 1 shared paper, 2020 · strength 0.11
- Qi Chen · 1 shared paper, 2020 · strength 0.11
- Xiaoqing Wu · 1 shared paper, 2020 · strength 0.11
- Tao Wang · 1 shared paper, 2020 · strength 0.11
- Ruochen Dong · 1 shared paper, 2020 · strength 0.11
- George C Prendergast · 1 shared paper, 2021 · strength 0.09
- Talia Golan · 1 shared paper, 2021 · strength 0.09
- Emanuel F. Petricoin · 1 shared paper, 2021 · strength 0.09
- Pankaj Kumar Singh · 1 shared paper, 2021 · strength 0.09
- Michael Jon Pishvaian · 1 shared paper, 2021 · strength 0.09
How to reach this person
A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.